Structural Biology Shared Service
结构生物学共享服务
基本信息
- 批准号:10267057
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-08 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced Malignant NeoplasmAmericanAreaBaltimoreBiometryCancer BiologyCancer CenterCellsChemicalsCollectionComprehensive Cancer CenterComputer AssistedConsultationsCryoelectron MicroscopyCrystallizationDataData AnalysesData CollectionDoctor of PhilosophyDrug DesignElectron MicroscopyEnzymesFacultyFlow CytometryFundingGenomicsGrantHuman ResourcesImageInvestigational TherapiesJournalsLaboratoriesLeadershipMalignant NeoplasmsMarylandMethodologyMethodsMicroscopeMissionMolecularMolecular BiologyMolecular Mechanisms of ActionMolecular ProbesMolecular StructureNuclear Magnetic ResonanceNucleic AcidsOutcomePathologyPeer ReviewPharmaceutical ChemistryPopulation SciencesPreparationPrincipal InvestigatorProteinsPublicationsResearchResearch DesignResearch PersonnelResolutionRoboticsRoentgen RaysSamplingScienceServicesSocietiesSourceStrategic PlanningStructural BiologistStructureSynchrotronsTechnologyTherapeuticTrainingUniversitiesX-Ray Crystallographyacronymsanticancer researchbasebench to bedsidebiobankcancer therapycollaborative environmentcomputer centercryogenicsdesigndetectordrug candidatedrug discoveryhormone related cancerinnovationinstrumentinstrumentationmedical schoolsmemberneoplasm immunotherapyparticleprogramsresearch studyscreeningstructural biologysuccesstumor immunology
项目摘要
20.0 Abstract: Structural Biology Shared Service
The Structural Biology Shared Service (SBSS) assists investigators in the collection and interpretation of
structural biology data derived from three technologies—cryogenic electron microscopy, X-ray crystallography,
and nuclear magnetic resonance—as a value-added means to advance cancer biology research. SBSS
supports users from all five research programs at the University of Maryland Marlene and Stewart Greenebaum
Comprehensive Cancer Center (UMGCCC). The structural biology data from SBSS help investigators derive the
molecular mechanisms of action of cancer-related proteins and enzymes and permit the design of molecular
agents, including molecular probes as drug candidates for research studies and potential cancer treatments.
The three technologies offer complementary approaches to understanding structure and biomolecule
mechanisms of action. The expertise of SBSS leadership directs investigators to the appropriate structural
biology method(s) that will most efficiently address their scientific questions and then provides strategies for
obtaining high-quality analysis. SBSS is heavily used. For example, 18 research groups use two or more
structural analysis methods. SBSS facilitates early-stage UMGCCC drug discovery in cooperation with other
UMGCCC shared services; the Computer Aided Drug Design Center (CADDC), headed by MacKerell (MSB);
and the Center for Biomolecular Therapeutics (CBT), directed by Weber (MSB). The Faculty Oversight
Committee, composed of SBSS users and external reviewers, assesses and provides guidance on current
services and strategic planning. Overall, SBSS provides UMGCCC investigators with access to state-of-the-art
structural biology instrumentation in a collaborative environment that is ideal for basic structure-based drug
design research to enable the advancement of high-impact cancer research and bench-to-bedside success. In
2019 SBSS supported studies by 56 investigators, 40 (71.4%) of whom were affiliated with UMGCCC. In 2019
SBSS supported $17.9 million of UMGCCC funding, all of which was peer reviewed. From 2015 to 2019, SBSS
supported 164 publications including those in high-impact journals such as Science, Cell, PNAS, Nucleic Acids
Research, Journal of the American Chemical Society, and Journal of Molecular Biology.
摘要:结构生物学共享服务
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Joseph Weber其他文献
David Joseph Weber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Joseph Weber', 18)}}的其他基金
Structure-based targeting of the C. difficile toxin (CDT) from hypervirulent bacterial strains
基于结构的高毒力细菌菌株中艰难梭菌毒素 (CDT) 的靶向
- 批准号:
10455150 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Signal Propagation in Protein Allostery: Mechanism and Evolution
蛋白质变构中的信号传播:机制和进化
- 批准号:
10326378 - 财政年份:2019
- 资助金额:
-- - 项目类别:
950 MHz NMR Spectrometer with Cryogenic Probe
带低温探头的 950 MHz NMR 波谱仪
- 批准号:
7839937 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Restoration of Tumor Suppression Activity in Malignant Melanoma
恶性黑色素瘤肿瘤抑制活性的恢复
- 批准号:
7812305 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Restoration of Tumor Suppression Activity in Malignant Melanoma
恶性黑色素瘤肿瘤抑制活性的恢复
- 批准号:
7250875 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Restoration of Tumor Suppression Activity in Malignant Melanoma
恶性黑色素瘤肿瘤抑制活性的恢复
- 批准号:
8188169 - 财政年份:2006
- 资助金额:
-- - 项目类别: